Kai Yang1, Hong Li1, Jin Dong1, Yan Dong1, Chang-Zheng Wang1. 1. Kai Yang, Department of General Surgery, Shijingshan Teaching Hospital of Capital Medical University, Beijing Shijingshan Hospital, Beijing 100043, China.
Abstract
AIM: To investigate the relationship between the metabolism of polyunsaturated fatty acids (PUFAs) and tumor-associated factors for predicting the outcome of colorectal carcinoma (CRC) in Chinese patients. METHODS: Fresh-frozen malignant and normal tissues from 82 Chinese patients with CRC were analyzed for PUFA composition using gas-liquid chromatography. The levels of vascular endothelial growth factor (VEGF), cyclooxygenase-2 (COX-2), prostaglandin E2 and platelet-derived growth factor (PDGF) were measured by enzyme-linked immunosorbent assay, and the levels of VEGF, p53 and Ki-67 were measured by immunohistochemistry. RESULTS: In malignant tissue, compared with normal tissue, the levels of total ω-6 PUFAs (24.64%±3.41% vs 26.77%±3.37%, P=0.00) and linoleic acid (LA) (15.46%±3.51% vs 18.30%±2.83%, P<0.01) were lower, whereas the levels of total ω-3 PUFAs (1.58%±0.74% vs 1.35%±0.60%, P<0.01) and dihomo-gamma-linolenic acid (DGLA) (1.32%±0.69% vs 0.85%±0.29%, P<0.01) were significantly higher. The ratios of arachidonic acid (AA)/LA (0.53±0.22 vs 0.42±0.19, P<0.01) and AA/total ω-6 PUFAs (0.31±0.09 vs 0.27±0.10, P<0.01) were also significantly higher in malignant tissue. The levels of PDGF (353.10±148.85 pg/mL vs 286.09±104.91 pg/mL, P<0.01), COX-2 (125.21±70.29 ng/mL vs 67.06±42.22 ng/mL, P<0.01) and VEGF (357.11±128.76 pg/mL vs 211.38±99.47 pg/mL, P<0.01) were also higher in malignant tissue compared to normal tissue. COX-2 was inversely correlated with LA (R=-0.3244, P<0.05) and positively correlated with AA/total ω-6 PUFAs (R=0.3083, P<0.05) and AA/LA (R=0.3001, P<0.05). The tissue level of LA was highest in poorly differentiated tumors (19.9%±6.3%, P<0.05), while the ratio of AA/ω-3 PUFAs was lowest in these tumors (10.8±2.6, P<0.05). In VEGF-positive tumors, the level of LA was higher (16.2%±3.7% vs 13.9%±2.7%, P<0.01), while the AA/ω-3PUFA, AA/ω-6 PUFA, and AA/LA ratios were lower than in VEGF-negative tumors (5.0±1.8 vs 6.7±3.3, 0.30±0.09 vs 0.34±0.09, 0.50±0.21 vs 0.61±0.21, P<0.01). CONCLUSION: The metabolism of PUFAs may play an important role in the evolution of inflammation-driven tumorigenesis in CRC and may be considered a potential marker for prognosis.
AIM: To investigate the relationship between the metabolism of polyunsaturated fatty acids (PUFAs) and tumor-associated factors for predicting the outcome of colorectal carcinoma (CRC) in Chinese patients. METHODS: Fresh-frozen malignant and normal tissues from 82 Chinese patients with CRC were analyzed for PUFA composition using gas-liquid chromatography. The levels of vascular endothelial growth factor (VEGF), cyclooxygenase-2 (COX-2), prostaglandin E2 and platelet-derived growth factor (PDGF) were measured by enzyme-linked immunosorbent assay, and the levels of VEGF, p53 and Ki-67 were measured by immunohistochemistry. RESULTS: In malignant tissue, compared with normal tissue, the levels of total ω-6 PUFAs (24.64%±3.41% vs 26.77%±3.37%, P=0.00) and linoleic acid (LA) (15.46%±3.51% vs 18.30%±2.83%, P<0.01) were lower, whereas the levels of total ω-3 PUFAs (1.58%±0.74% vs 1.35%±0.60%, P<0.01) and dihomo-gamma-linolenic acid (DGLA) (1.32%±0.69% vs 0.85%±0.29%, P<0.01) were significantly higher. The ratios of arachidonic acid (AA)/LA (0.53±0.22 vs 0.42±0.19, P<0.01) and AA/total ω-6 PUFAs (0.31±0.09 vs 0.27±0.10, P<0.01) were also significantly higher in malignant tissue. The levels of PDGF (353.10±148.85 pg/mL vs 286.09±104.91 pg/mL, P<0.01), COX-2 (125.21±70.29 ng/mL vs 67.06±42.22 ng/mL, P<0.01) and VEGF (357.11±128.76 pg/mL vs 211.38±99.47 pg/mL, P<0.01) were also higher in malignant tissue compared to normal tissue. COX-2 was inversely correlated with LA (R=-0.3244, P<0.05) and positively correlated with AA/total ω-6 PUFAs (R=0.3083, P<0.05) and AA/LA (R=0.3001, P<0.05). The tissue level of LA was highest in poorly differentiated tumors (19.9%±6.3%, P<0.05), while the ratio of AA/ω-3 PUFAs was lowest in these tumors (10.8±2.6, P<0.05). In VEGF-positive tumors, the level of LA was higher (16.2%±3.7% vs 13.9%±2.7%, P<0.01), while the AA/ω-3PUFA, AA/ω-6 PUFA, and AA/LA ratios were lower than in VEGF-negative tumors (5.0±1.8 vs 6.7±3.3, 0.30±0.09 vs 0.34±0.09, 0.50±0.21 vs 0.61±0.21, P<0.01). CONCLUSION: The metabolism of PUFAs may play an important role in the evolution of inflammation-driven tumorigenesis in CRC and may be considered a potential marker for prognosis.
Authors: John A Baron; Bernard F Cole; Robert S Sandler; Robert W Haile; Dennis Ahnen; Robert Bresalier; Gail McKeown-Eyssen; Robert W Summers; Richard Rothstein; Carol A Burke; Dale C Snover; Timothy R Church; John I Allen; Michael Beach; Gerald J Beck; John H Bond; Tim Byers; E Robert Greenberg; Jack S Mandel; Norman Marcon; Leila A Mott; Loretta Pearson; Fred Saibil; Rosalind U van Stolk Journal: N Engl J Med Date: 2003-03-06 Impact factor: 91.245
Authors: Jonathan Himmelfarb; Stephen Phinney; T Alp Ikizler; Jane Kane; Ellen McMonagle; Guy Miller Journal: J Ren Nutr Date: 2007-09 Impact factor: 3.655
Authors: Esther Lopez-Garcia; Matthias B Schulze; JoAnn E Manson; James B Meigs; Christine M Albert; Nader Rifai; Walter C Willett; Frank B Hu Journal: J Nutr Date: 2004-07 Impact factor: 4.798
Authors: Lígia A B M Mendonça; Rosângela Dos Santos Ferreira; Rita de Cássia Avellaneda Guimarães; Alinne P de Castro; Octávio L Franco; Rosemary Matias; Cristiano M E Carvalho Journal: Front Oncol Date: 2018-09-05 Impact factor: 6.244
Authors: Adriana Mika; Alicja Pakiet; Aleksandra Czumaj; Zbigniew Kaczynski; Ivan Liakh; Jarek Kobiela; Adrian Perdyan; Krystian Adrych; Wojciech Makarewicz; Tomasz Sledzinski Journal: J Clin Med Date: 2020-04-12 Impact factor: 4.241
Authors: Alicja Pakiet; Jarosław Kobiela; Piotr Stepnowski; Tomasz Sledzinski; Adriana Mika Journal: Lipids Health Dis Date: 2019-01-26 Impact factor: 3.876